Position: Talent Retention
(Ramón y Cajal fellow)
AQU Prof. Agregado
Ana Belen Alvarez Palomo
b.alvarez (at) ub.edu
jordi.requena (at) ub.edu
Dr. Michael Edel
Department of Biomedicina
Faculty of Medicine, 143 Casanova
08036 Barcelona (Spain)
93 402 4518
michaeledel (at) ub.edu
Dr. Michael Edel is a Group Leader and an accredited Associate Professor at the University of Barcelona, Faculty of Medicine with rolling Spanish national project grant funding. He is an expert in cancer genetics and cell pluripotency. His research is concerned with the role of the cell cycle in attaining a pluripotent state, neural stem cell development and the development of cancer. His work has appeared in Cell (2005), Nature Biotechnology (2008) and Genes & Development (2010) and two of his publications are in the world’s top 1% most cited. He leads a group dedicated to developing new methods to make genetically stable high quality clinical grade stem cells and pluripotent stem cells to study human cardiac and neural disease with an extensive international and national collaboration network of excellence in stem cell research. Consequently, he is affiliated as Senior Research Fellow at the University of Western Australia Department of Anatomy/Harry Perkins Institute (CCTRM) and adjunct International Research Fellow at the Victor Chang Cardiac Research Institute, Sydney, Australia.
Education: The University of Western Australia, NEDLANDS, WA 6009, AUSTRALIA.
Jan-2000 Sep: Doctor of Philosophy (Pathology). 1990 Jan–1991 Mar: Post-Graduate Diploma in Education. 1985 Jan-1989 Mar: Bachelor of Science with Honours (Anatomy).
· Michael J. Edel, Stephanie Boue, Cristina Menchon, Adriana Sanchez-Danes and Juan Carlos Izpisua Belmonte. (2010) Rem2 GTPase controls proliferation and apoptosis of neurons during zebra fish embryo development. Cell Cycle, 9(14).
· McLenachan S, Zhang D, Palomo AB, Edel MJ, Chen FK (2013) mRNA transfection of mouse and human neural stem cell cultures. PLoS One. Dec 26;8(12).
· Edel, Michael J, Menchon C, Menendez S, Raya A, Izpisua Belmonte JC (2010) Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1. Genes & Development. 24: 561-573.
· Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilic J, Pekarik V, Tiscornia G, Edel MJ, Boué S, Izpisúa Belmonte JC. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol Nov;26(11):1276-84.
· Epping MT, Wang L, Edel MJ, Carlée L, Hernandez M, Bernards R. (2005) The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell Sep 23;122(6)835-47.